Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro (Q39430360)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro (English)

1 reference

Europe PubMed Central

11 September 2017

oligodendrocyte

1 reference

based on heuristic

inferred from title

hypermethylation

1 reference

based on heuristic

inferred from title

author name string

L M Dittmann

1

1 reference

Europe PubMed Central

11 September 2017

A Danner

2

1 reference

Europe PubMed Central

11 September 2017

J Gronych

3

1 reference

Europe PubMed Central

11 September 2017

M Wolter

4

1 reference

Europe PubMed Central

11 September 2017

K Stühler

5

1 reference

Europe PubMed Central

11 September 2017

M Grzendowski

6

1 reference

Europe PubMed Central

11 September 2017

N Becker

7

1 reference

Europe PubMed Central

11 September 2017

J Bageritz

8

1 reference

Europe PubMed Central

11 September 2017

V Goidts

9

1 reference

Europe PubMed Central

11 September 2017

G Toedt

10

1 reference

Europe PubMed Central

11 September 2017

J Felsberg

11

1 reference

Europe PubMed Central

11 September 2017

M C Sabel

12

1 reference

Europe PubMed Central

11 September 2017

S Barbus

13

1 reference

Europe PubMed Central

11 September 2017

G Reifenberger

14

1 reference

Europe PubMed Central

11 September 2017

P Lichter

15

1 reference

Europe PubMed Central

11 September 2017

B Tews

16

1 reference

Europe PubMed Central

11 September 2017

language of work or name

0 references

publication date

12 December 2011

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

31

1 reference

Europe PubMed Central

11 September 2017

29

1 reference

Europe PubMed Central

11 September 2017

3409-3418

1 reference

Europe PubMed Central

11 September 2017

https://scigraph.springernature.com/pub.10.1038/onc.2011.513

0 references

Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Simultaneous extraction of nucleic acids and proteins from tissue specimens by ultracentrifugation: A protocol using the high-salt protein fraction for quantitative proteome analysis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Peroxiredoxins, oxidative stress, and cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Genetic alterations and signaling pathways in the evolution of gliomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Adjuvant treatment of high grade gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.513

21 January 2018

Identifiers

10.1038/ONC.2011.513

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39430360&oldid=2004711157"